[HTML][HTML] Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells
C Tolg, N Sabha, R Cortese, T Panchal, A Ahsan… - Laboratory …, 2011 - Elsevier
Host cell and bacterial factors determine severity and duration of infections. To allow for
bacteria pathogenicity and persistence, bacteria have developed mechanisms that modify …
bacteria pathogenicity and persistence, bacteria have developed mechanisms that modify …
Uropathogenic Escherichia Coli Infection: Potential Importance of Epigenetics
C Tolg, DJ Bägli - Epigenomics, 2012 - Taylor & Francis
Patients suffering from recurrent urinary tract infections (UTIs) may be maintained on
antibiotic prophylaxis, or even treated by surgery. However, there are no biological data on …
antibiotic prophylaxis, or even treated by surgery. However, there are no biological data on …
Assessing the use of p16INK4a promoter gene methylation in serum for detection of bladder cancer
MT Valenzuela, R Galisteo, A Zuluaga, M Villalobos… - European urology, 2002 - Elsevier
Objective: This study was undertaken to investigate whether hypermethylation in p16INK4a
gene promoter could serve as plasma biomarker of bladder cancer. Methods and Patients …
gene promoter could serve as plasma biomarker of bladder cancer. Methods and Patients …
Multiple mechanisms downregulate CDKN1C in human bladder cancer
MJ Hoffmann, AR Florl, HH Seifert… - International journal of …, 2005 - Wiley Online Library
Expression of the imprinted CDKN1C gene at chromosome 11p15. 5 encoding the cell cycle
inhibitor p57KIP2 is disturbed in Beckwith‐Wiedemann syndrome and in several human …
inhibitor p57KIP2 is disturbed in Beckwith‐Wiedemann syndrome and in several human …
p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer
K Kawamoto, H Enokida, T Gotanda, H Kubo… - Biochemical and …, 2006 - Elsevier
Promoter hypermethylation is one of the putative mechanisms underlying the inactivation of
negative cell-cycle regulators. We examined whether the methylation status of p16INK4a …
negative cell-cycle regulators. We examined whether the methylation status of p16INK4a …
Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled
CS Reigstad, SJ Hultgren, JI Gordon - Journal of Biological Chemistry, 2007 - ASBMB
Uropathogenic Escherichia coli (UPEC), the principal cause of urinary tract infection in
women, colonizes the gut as well as the genitourinary tract. Studies of mice inoculated with …
women, colonizes the gut as well as the genitourinary tract. Studies of mice inoculated with …
[HTML][HTML] The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis
D Qi, J Li, M Jiang, C Liu, Y Hu, M Li, J Su… - … Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose: Many scientific evidences suggested that the methylation of p16INK4a (p16) was
associated with bladder cancer, but some existing studies have yielded inconclusive results …
associated with bladder cancer, but some existing studies have yielded inconclusive results …
DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial …
T Nakagawa, Y Kanai, S Ushijima, T Kitamura… - The Journal of …, 2005 - Elsevier
PURPOSE:: We elucidated the significance of aberrant DNA methylation on multiple CpG
islands and its correlation with DNA methyltransferase DNMT1 protein expression during …
islands and its correlation with DNA methyltransferase DNMT1 protein expression during …
Comprehensive Analysis of CDKN2A Status in Microdissected Urothelial Cell Carcinoma Reveals Potential Haploinsufficiency, a High Frequency of Homozygous Co …
EJ Chapman, P Harnden, P Chambers, C Johnston… - Clinical cancer …, 2005 - AACR
Purpose: There are significant differences in reported frequencies, modes of inactivation,
and clinical significance of CDKN2A in urothelial cell carcinoma (UCC). We aimed to …
and clinical significance of CDKN2A in urothelial cell carcinoma (UCC). We aimed to …
A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer
DNA hypermethylation has emerged as a molecular biomarker for the evaluation of cancer
diagnosis and prognosis. We define a methylation signature of bladder cancer and evaluate …
diagnosis and prognosis. We define a methylation signature of bladder cancer and evaluate …